DRJD
ActiveSummary
DRJD has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €86,774 and a net result of €49,056. The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
- Equity
- €86,774
- Profit
- €49,056
Why 94raises riskFounded in 2024lowers riskLiquidity: current ratio 4.99, cash €89,008Size: total assets €106,245Equity €86,774 (81.7% of total assets)Show the evidence
Checked score
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 81% on solvency, 86% on liquidity, 90% on profitability and 94% on growth.
The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 2 accounts on average 12 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
- Annual accounts filedfinancial year 2025 · micro…
- Liquidity more than doubledcurrent ratio 4.99
- Annual accounts filedfinancial year 2024 · micro…
Financials · financial year 2025, micro format
2024 to 2025, 2 financial years
The operating result rises in 2025; 2025 is 42% above 2024.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Use the arrow keys on the chart for the figures per year.
Peer companies
Historical observationOf the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 95.9% are still going.
- Micro
- 2 to 5 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €6,700 | €6,591 | ▼ 1.6% |
| Other operating charges640/8 | €287 | €186 | ▼ 35.0% |
| Gross operating margin9900 | €51,355 | €69,668 | ▲ 35.7% |
| Operating profit (loss)9901 | €44,368 | €62,892 | ▲ 41.7% |
| Financial charges65/66B | €795 | €411 | ▼ 48.3% |
| Recurring financial charges65 | €795 | €411 | ▼ 48.3% |
| Profit (loss) for the period before taxes9903 | €43,573 | €62,481 | ▲ 43.4% |
| Income taxes67/77 | €9,355 | €13,425 | ▲ 43.5% |
| Profit (loss) for the period9904 | €34,218 | €49,056 | ▲ 43.4% |
| Profit (loss) for the period to be appropriated9905 | €34,218 | €49,056 | ▲ 43.4% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €64,629 | €106,245 | ▲ 64.4% |
| Fixed assets21/28 | €15,276 | €10,759 | ▼ 29.6% |
| Tangible fixed assets22/27 | €15,276 | €10,009 | ▼ 34.5% |
| Furniture and vehicles24 | €15,276 | €10,009 | ▼ 34.5% |
| Financial fixed assets28 | - | €750 | - |
| Current assets29/58 | €49,353 | €95,486 | ▲ 93.5% |
| Amounts receivable within one year40/41 | €11,386 | €1,000 | ▼ 91.2% |
| Trade receivables40 | €11,386 | €1,000 | ▼ 91.2% |
| Cash at bank and in hand54/58 | €37,306 | €89,008 | ▲ 139% |
| Deferred charges and accrued income490/1 | €662 | €5,479 | ▲ 728% |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €64,629 | €106,245 | ▲ 64.4% |
| Equity10/15 | €37,718 | €86,774 | ▲ 130% |
| Contributions10/11 | €3,500 | €3,500 | = |
| Profit (loss) carried forward14 | €34,218 | €83,274 | ▲ 143% |
| Amounts payable17/49 | €26,911 | €19,471 | ▼ 27.6% |
| Amounts payable within one year42/48 | €26,744 | €19,136 | ▼ 28.4% |
| Trade debts44 | €204 | €584 | ▲ 185% |
| Suppliers440/4 | €204 | €584 | ▲ 185% |
| Taxes, remuneration and social security45 | €11,844 | €7,914 | ▼ 33.2% |
| Taxes450/3 | €9,355 | €5,525 | ▼ 40.9% |
| Remuneration and social security454/9 | €2,488 | €2,389 | ▼ 4.0% |
| Other amounts payable47/48 | €14,696 | €10,638 | ▼ 27.6% |
| Accrued charges and deferred income492/3 | €167 | €336 | ▲ 101% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €34,218 | €49,056 | ▲ 43.4% |
| + Depreciation and write-downs630 | €6,700 | €6,591 | ▼ 1.6% |
| Operating cash flow (approximation) | €40,918 | €55,647 | ▲ 36.0% |
| Investment in fixed assets (approximation) | - | -€2,074 | - |
| Change in cash | - | €51,702 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (2)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro format | 22-07-2026 | 2026-00317650 |
| 31-12-2024 | micro format | 16-07-2025 | 2025-00274870 |
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Mandate history
- Board
| Name | Functions and periods |
|---|---|
| DEDOBBELEER Jill Laure |
|
Owners and capital
Capital and shareholders
- DEDOBBELEER Jill Laure sole founder · 100% at incorporation
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 19-06-2024 Incorporation · €3,500 · 100 shares
Group and network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
History
Acts, filings and financial milestones
19-06
Gazette deed
IncorporationAppointment: DEDOBBELEER Jill Laure (director) · Founder · Founding capital8 facts ▸
- Incorporation, 06-06-2024
- Founder, DEDOBBELEER Jill Laure
- Founding capital, €3,500
- Other provision, “autorisation préalable, autorisations ou licences préalables ou conditions possibles accès profession” (deed in French)
- Registered office clause, “Avenue des Buissonnets 43,1020 Bruxelles” (deed in French)
- Board rule, 1
- Director appointment, DEDOBBELEER Jill Laure (director (not named in the articles))
- Pre-incorporation commitments, “takeover, engagements,obligations,activités au nom et pour compte société en formation” (deed in French)
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 21818F0014/00S000 | Brussels | 969 m² | 1 · 120 m² | 14.0 m · 4 |
How the parcels are linked
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “La société a pour objet,tant en Belgique qu’à l’étranger,l'exercice de l’art de guérir,et plus particulièrement dans le domaine médical de…” (deed in French)
9 activities (deed in French)
- La société a pour objet,tant en Belgique qu’à l’étranger,l'exercice de l’art de guérir,et plus particulièrement dans le domaine médical de la médecine générale et ce par un ou plusieurs praticiens légalement habilités à exercer la profession de médecin en Belgique,inscrits au Tableau de l’Ordre des Médecins,et pratiquant ou appelés à pratiquer dans le cadre sociétaire.
- La médecine est exercée au nom et pour le compte de la société.
- En cas de pluralité d’actionnaires,ceux-ci mettent en commun la totalité de leur activité médicale au sein de la société.
- Les honoraires sont perçus par et pour la société.
- La société a pour but de leur permettre de pratiquer une médecine de qualité,dans le respect de la déontologie et de la liberté thérapeutique et diagnostique,de la dignité et de l'indépendance professionnelle du praticien,ainsi que du libre choix du patient,par l'amélioration et la rationalisation de leur équipement professionnel,notamment en assurant la gestion du cabinet médical,en ce compris l'acquisition,la location et l'entretien du matériel médical et des biens d'équipement,la facturation et la perception d'honoraires médicaux,la mise à disposition de tout ce qui est nécessaire à la pratique de l'art de guérir.
- La société pourra faire tout acte nécessaire et/ou indispensable à l'accomplissement de son objet et plus particulièrement toute transaction mobilière et immobilière concernant les locaux médicaux et non médicaux,l'achat du matériel médical et non médical,l'engagement du personnel administratif,soignant,pratiquant ou appelé à pratiquer dans la société.
- La société pourra,d'une façon générale,accomplir toutes opérations se rapportant directement ou indirectement à la réalisation de son objet,sans en modifier la vocation médicale.
- La société pourra s'intéresser par voie d'apport,de fusion,de souscription ou de toute autre manière,dans toutes entreprises,associations ou sociétés ayant un objet similaire,analogue ou connexe,ou de nature à favoriser celui de la société,pour autant que cette participation fasse l'objet également d'un contrat.
- A titre accessoire,la société pourra également avoir pour objet la constitution,la gestion,et la valorisation d’un patrimoine mobilier et immobilier,notamment par l’achat,la vente,la location,la mise en location,la construction,le tout au sens le plus large,pour autant que n’en soit altérée sa vocation prioritairement médicale,et que ces opérations s’inscrivent dans les limites d’une gestion en bon père de famille et n’aient pas un caractère répétitif et/ou commercial.
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- DRJD
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région de Bruxelles Capitale, transfert communiqué en temps opportun au Conseil provincial compétent” (deed in French)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Indéterminée sauf décision contraire, organe d'administration” (deed in French)“Correspondre prestations réellement accomplies,sans détriment autres administrateurs/actionnaires, fixe ou proportionnelle” (deed in French)1 more provision on this in the deed
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- One provision in the deed
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Nouvel actionnaire qu’accord unanime autres actionnaires, cession entre vifs ou transmission cause mort qu’avec accord unanime autres…” (deed in French)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Third Friday of June at 18:00
Oversight and winding up
- Statutory auditorA statutory auditor is a registered auditor who checks the accounts; small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Articles 2:76 et suivants CSA, en tout temps par assemblée générale formes modifications statuts” (deed in French)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Assemblée générale, problématiques médicales,dossiers médicaux,vie privée patients,secret professionnel” (deed in French)